Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis

T Greenstein, BB Aldridge - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
Combination therapy is necessary to treat tuberculosis to decrease the rate of disease
relapse and prevent the acquisition of drug resistance, and shorter regimens are urgently …

Distinct bacterial pathways influence the efficacy of antibiotics against Mycobacterium tuberculosis

MM Bellerose, MK Proulx, CM Smith, RE Baker… - …, 2020 - Am Soc Microbiol
Effective tuberculosis treatment requires at least 6 months of combination therapy.
Alterations in the physiological state of the bacterium during infection are thought to reduce …

Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine

S Stanley, Q Liu, SM Fortune - Frontiers in Cellular and Infection …, 2022 - frontiersin.org
In the face of the unrelenting global burden of tuberculosis (TB), antibiotics remain our most
effective tools to save lives and control the spread of Mycobacterium tuberculosis (Mtb) …

[HTML][HTML] Understanding anti-tuberculosis drug efficacy: rethinking bacterial populations and how we model them

D Evangelopoulos, JD da Fonseca… - International Journal of …, 2015 - Elsevier
Tuberculosis still remains a global health emergency, claiming 1.5 million lives in 2013. The
bacterium responsible for this disease, Mycobacterium tuberculosis (M. tb), has successfully …

The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis

NJE Waller, CY Cheung, GM Cook… - Nature …, 2023 - nature.com
The increasing incidence of drug resistance in Mycobacterium tuberculosis has diminished
the efficacy of almost all available antibiotics, complicating efforts to combat the spread of …

Pre-clinical tools for predicting drug efficacy in treatment of tuberculosis

H Margaryan, DD Evangelopoulos, L Muraro Wildner… - Microorganisms, 2022 - mdpi.com
Combination therapy has, to some extent, been successful in limiting the emergence of drug-
resistant tuberculosis. Drug combinations achieve this advantage by simultaneously acting …

Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development

L Nguyen, J Pieters - Annual review of pharmacology and …, 2009 - annualreviews.org
Recent worldwide emergence of multidrug-resistant and extensively drug-resistant
tuberculosis is threatening to destabilize tuberculosis control programs and urging global …

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis

G Mancuso, A Midiri, S De Gaetano, E Ponzo… - Microorganisms, 2023 - mdpi.com
Antibiotics have played a crucial role in the reduction in the incidence of TB globally as
evidenced by the fact that before the mid-20th century, the mortality rate within five years of …

Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis

DF Ackart, L Hascall-Dove, SM Caceres… - Pathogens and …, 2014 - academic.oup.com
There is an urgent need to improve methods used to screen antituberculosis drugs. An in
vitro assay was developed to test drug treatment strategies that specifically target drug …

Heterogeneous host–pathogen encounters coordinate antibiotic resilience in Mycobacterium tuberculosis

R Mishra, V Yadav, M Guha, A Singh - Trends in microbiology, 2021 - cell.com
Successful treatment of tuberculosis (TB) depends on the eradication of its causative agent
Mycobacterium tuberculosis (Mtb) in the host. However, the emergence of phenotypically …